Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis [NA]
A completed clinical trial evaluated the effect of HIT in patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis,…
-
CLINICAL_TRIALS trial_result · 2018-01-30Clinical Trial Update: Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults [Phase 3]
A Phase 3 trial comparing liraglutide versus bariatric surgery for weight loss and metabolic endpoints in obese Asian adults with NAFLD/NASH…
-
CLINICAL_TRIALS research · 2017-11-30Clinical Trial Update: Inflammation and Steatosis: the Role of Alpha-defensin
A clinical trial investigating the role of alpha-defensin in liver inflammation and fatty liver (steatosis); current status is not reported.
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers. [Phase 1]
Phase 1 drug-drug interaction study assessed interactions between EDP-305 and midazolam, caffeine, and rosuvastatin in healthy volunteers; t…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating a Mediterranean lifestyle intervention in patients with non-alcoholic fatty liver disease (NAFLD) and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Histological Improvement of NASH With Prebiotic [NA]
A completed clinical trial investigated histological improvement in non-alcoholic fatty liver disease (NASH) using a prebiotic therapy, sugg…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin [Phase 1]
A Phase 1 study evaluated how non-alcoholic steatohepatitis affects the pharmacokinetics of the radiopharmaceutical Technetium-99m mebrofeni…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
Clinical trial update focusing on a non-invasive method to diagnose non-alcoholic steatohepatitis in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Safety and Tolerability Study of SHP626 in Overweight and Obese Adults [Phase 1]
Phase 1 safety and tolerability trial of SHP626 in overweight and obese adults with non-alcoholic steatohepatitis has completed with posted …
-
CLINICAL_TRIALS trial_result · 2016-10-25Clinical Trial Update: Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D [Phase 2]
A Phase 2 trial evaluating the use of Vitamin D for treatment of non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV
A completed clinical trial evaluating the relationship between metabolic abnormalities and hepatic steatosis in people with HIV.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 clinical trial evaluating the effect of fish oil on non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic Steatohepatitis [Phase 2]
Phase II trial of silymarin for non-cirrhotic patients with non-alcoholic steatohepatitis has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: DHA and Vitamin D in Children With Biopsy-proven NAFLD [Phase 3]
A Phase 3 clinical trial evaluating DHA and vitamin D in children with biopsy-confirmed non-alcoholic fatty liver disease (NAFLD) and non-al…
-
CLINICAL_TRIALS research · 2016-01-11Clinical Trial Update: Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
A Mayo Clinic clinical trial update describing a completed study that investigates how muscle insulin resistance contributes to the developm…
-
CLINICAL_TRIALS withdrawal · 2015-10-12Clinical Trial Update: Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis [Phase 3]
Phase 3 trial evaluating pentoxifylline with vitamin E versus vitamin E alone for non-alcoholic steatohepatitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Impact of Fructose Consumption on Intestinal Permeability in Non-alcoholic Fatty Liver Disease (NAFLD) - a Pilot Study. [NA]
A pilot clinical trial investigates how fructose intake affects intestinal permeability in people with non-alcoholic fatty liver disease and…
-
CLINICAL_TRIALS withdrawal · 2015-08-25Clinical Trial Update: Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
This clinical trial update notes the withdrawal of a study investigating a biomarker for pediatric non-alcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis [Phase 1]
Phase 1 study completed to evaluate the safety of GR-MD-02 in subjects with non-alcoholic steatohepatitis (NASH).
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis [Phase 4]
Phase 4 trial evaluating anti-fatigue effects of Korean Red Ginseng in patients with non-alcoholic fatty liver disease has completed, with r…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis [Phase 2]
Phase 2 trial comparing ezetimibe to placebo in non-alcoholic steatohepatitis has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) [Phase 2]
This Phase 2 double-blind, placebo-controlled trial evaluated two doses of EPA-E in patients with non-alcoholic steatohepatitis (NASH); resu…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis [Phase 4]
Phase 4 trial evaluating a combination of Siliphos selenium, methionine, and alpha-lipoic acid in fatty liver disease and non-alcoholic stea…
-
CLINICAL_TRIALS trial_result · 2014-08-18Clinical Trial Update: Beta Glucosylceramide for Treatment of NASH [Phase 1, Phase 2]
Phase 1/2 trial evaluating Beta Glucosylceramide for non-alcoholic steatohepatitis has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-31Clinical Trial Update: A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 1, Phase 2]
A Phase 1/2 study evaluated cysteamine therapy in humans with non-alcoholic steatohepatitis (fatty liver). The trial is completed with resul…